表紙
市場調査レポート

末梢血管ステント:パイプライン分析

Peripheral Vascular Stents - Pipeline Review, 2015

発行 GlobalData 商品コード 223329
出版日 ページ情報 英文 166 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
末梢血管ステント:パイプライン分析 Peripheral Vascular Stents - Pipeline Review, 2015
出版日: 2015年04月28日 ページ情報: 英文 166 Pages
概要

当レポートでは、世界各国で現在開発・治験中の末梢血管ステントのパイプライン製品について分析し、全体的な開発の進行状況や、企業間・地域間の比較、主要企業および各社のパイプライン製品の概要といった情報を取りまとめてお届けします。

第1章 目次

第2章 イントロダクション

  • 末梢血管ステントの概要

第3章 開発中の製品

  • パイプライン製品:開発段階別
  • パイプライン製品:セグメント別
  • パイプライン製品:地域別
  • パイプライン製品:認証段階別
  • パイプライン製品:(推定) 認可時期別
  • 現在進行中の治験

第4章 開発中のパイプライン製品:企業別

  • 末梢血管ステントの開発企業:パイプライン製品、開発段階別
  • 末梢血管ステント:パイプライン製品、開発段階別

第5章 企業・製品の概要

  • 3D Biotek, LLC
    • パイプライン製品および現在進行中の治験の概要
  • 480 Biomedical, Inc.
  • Abbott Vascular Inc.
  • Andramed GmbH
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Contego Medical, LLC
  • Cook Medical Incorporated
  • Cordis Corporation
  • CorInnova, Inc.
  • Cytograft Tissue Engineering, Inc.
  • Elixir Medical Corporation
  • HEXACATH
  • InspireMD, Inc.
  • Lifetech Scientific (Shenzhen) Co., Ltd.
  • MicroVention, Inc.
  • ニプロ
  • NSVascular, Inc.
  • Palmaz Scientific, Inc.
  • Stentys, SA
  • Stron Medical
  • Taewoong Medical Co.,Ltd.
  • Tepha, Inc.
  • テルモ
  • University of Texas Medical Branch at Galveston
  • Veniti, Inc.
  • Veryan Medical Limited
  • VueKlar Cardiovascular Ltd.
  • W. L. Gore & Associates, Inc.

第6章 近年の市場動向

第7章 付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDME0008EPD

GlobalData's Medical Devices sector report, "Peripheral Vascular Stents - Pipeline Review, 2015" provides an overview of Peripheral Vascular Stents currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key peripheral vascular stents pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Peripheral Vascular Stents products under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Peripheral Vascular Stents and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Peripheral Vascular Stents under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Peripheral Vascular Stents Overview

3. Products under Development

  • 3.1. Peripheral Vascular Stents - Pipeline Products by Stage of Development
  • 3.2. Peripheral Vascular Stents - Pipeline Products by Segment
  • 3.3. Peripheral Vascular Stents - Pipeline Products by Territory
  • 3.4. Peripheral Vascular Stents - Pipeline Products by Regulatory Path
  • 3.5. Peripheral Vascular Stents - Pipeline Products by Estimated Approval Date
  • 3.6. Peripheral Vascular Stents - Ongoing Clinical Trials

4. Peripheral Vascular Stents - Pipeline Products under Development by Companies

  • 4.1. Peripheral Vascular Stents Companies - Pipeline Products by Stage of Development
  • 4.2. Peripheral Vascular Stents - Pipeline Products by Stage of Development

5. Peripheral Vascular Stents Companies and Product Overview

  • 5.1. 3D Biotek, LLC Company Overview
    • 5.1.1. 3D Biotek, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. 480 Biomedical, Inc. Company Overview
    • 5.2.1. 480 Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Abbott Vascular Inc. Company Overview
    • 5.3.1. Abbott Vascular Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Andramed GmbH Company Overview
    • 5.4.1. Andramed GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Biotronik SE & Co. KG Company Overview
    • 5.5.1. Biotronik SE & Co. KG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Boston Scientific Corporation Company Overview
    • 5.6.1. Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. Contego Medical, LLC Company Overview
    • 5.7.1. Contego Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. Cook Medical Incorporated Company Overview
    • 5.8.1. Cook Medical Incorporated Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Cordis Corporation Company Overview
    • 5.9.1. Cordis Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. CorInnova, Inc. Company Overview
    • 5.10.1. CorInnova, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. Cytograft Tissue Engineering, Inc. Company Overview
    • 5.11.1. Cytograft Tissue Engineering, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. Elixir Medical Corporation Company Overview
    • 5.12.1. Elixir Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. HEXACATH Company Overview
    • 5.13.1. HEXACATH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. InspireMD, Inc. Company Overview
    • 5.14.1. InspireMD, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. Lifetech Scientific (Shenzhen) Co., Ltd. Company Overview
    • 5.15.1. Lifetech Scientific (Shenzhen) Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. MicroVention, Inc. Company Overview
    • 5.16.1. MicroVention, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17. Nipro Corporation Company Overview
    • 5.17.1. Nipro Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18. NSVascular, Inc. Company Overview
    • 5.18.1. NSVascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19. Palmaz Scientific, Inc. Company Overview
    • 5.19.1. Palmaz Scientific, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20. Stentys, SA Company Overview
    • 5.20.1. Stentys, SA Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21. Stron Medical Company Overview
    • 5.21.1. Stron Medical Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22. Taewoong Medical Co.,Ltd. Company Overview
    • 5.22.1. Taewoong Medical Co.,Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23. Tepha, Inc. Company Overview
    • 5.23.1. Tepha, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24. Terumo Corporation Company Overview
    • 5.24.1. Terumo Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25. University of Texas Medical Branch at Galveston Company Overview
    • 5.25.1. University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26. Veniti, Inc. Company Overview
    • 5.26.1. Veniti, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.27. Veryan Medical Limited Company Overview
    • 5.27.1. Veryan Medical Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.28. VueKlar Cardiovascular Ltd. Company Overview
    • 5.28.1. VueKlar Cardiovascular Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.29. W. L. Gore & Associates, Inc. Company Overview
    • 5.29.1. W. L. Gore & Associates, Inc. Pipeline Products & Ongoing Clinical Trials Overview

6. Peripheral Vascular Stents- Recent Developments

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Peripheral Vascular Stents - Pipeline Products by Stage of Development
  • Table 2: Peripheral Vascular Stents - Pipeline Products by Segment
  • Table 3: Peripheral Vascular Stents - Pipeline Products by Territory
  • Table 4: Peripheral Vascular Stents - Pipeline Products by Regulatory Path
  • Table 5: Peripheral Vascular Stents - Pipeline Products by Estimated Approval Date
  • Table 6: Peripheral Vascular Stents - Ongoing Clinical Trials
  • Table 7: Peripheral Vascular Stents Companies - Pipeline Products by Stage of Development
  • Table 8: Peripheral Vascular Stents - Pipeline Products by Stage of Development
  • Table 9: 3D Biotek, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: Bioresorbable Drug Eluting Peripheral Polymer Stent - Product Status
  • Table 11: Bioresorbable Drug Eluting Peripheral Polymer Stent - Product Description
  • Table 12: 480 Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 13: Stanza Bioresorbable Pediatric Scaffold - Product Status
  • Table 14: Stanza Bioresorbable Pediatric Scaffold - Product Description
  • Table 15: Stanza Bioresorbable Self-Expanding Scaffold - Product Status
  • Table 16: Stanza Bioresorbable Self-Expanding Scaffold - Product Description
  • Table 17: Stanza Drug Eluting Bioresorbable Scaffold - Product Status
  • Table 18: Stanza Drug Eluting Bioresorbable Scaffold - Product Description
  • Table 19: 480 Biomedical, Inc. - Ongoing Clinical Trials Overview
  • Table 20: Stanza Drug Eluting Bioresorbable Scaffold - An Evaluation of the 480 Biomedical STANZA Drug-Eluting Resorbable Scaffold (DRS) System in the Treatment of de Novo SFA Lesions
  • Table 21: Abbott Vascular Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 22: ESPRIT Bioresorbable Vascular Scaffold - Product Status
  • Table 23: ESPRIT Bioresorbable Vascular Scaffold - Product Description
  • Table 24: Next Generation SUPERA Delivery System - Product Status
  • Table 25: Next Generation SUPERA Delivery System - Product Description
  • Table 26: Abbott Vascular Inc. - Ongoing Clinical Trials Overview
  • Table 27: ESPRIT Bioresorbable Vascular Scaffold - A Clinical Evaluation of the Abbott Vascular ESPRIT BVS (Bioresorbable Vascular Scaffold) System for the Treatment of Subjects With Symptomatic Claudication From Occlusive Vascular Disease of the Superficial Femoral (SFA) or Common or External Iliac Arteries
  • Table 28: Andramed GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 29: AndraStent U-Flex Peripheral Nitinol Stent System 5F - Product Status
  • Table 30: AndraStent U-Flex Peripheral Nitinol Stent System 5F - Product Description
  • Table 31: AndraStent U-Flex Peripheral Nitinol Stent System 6F - Product Status
  • Table 32: AndraStent U-Flex Peripheral Nitinol Stent System 6F - Product Description
  • Table 33: AndraStent XL - Product Status
  • Table 34: AndraStent XL - Product Description
  • Table 35: AndraStent XXL - Product Status
  • Table 36: AndraStent XXL - Product Description
  • Table 37: Biotronik SE & Co. KG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 38: Astron Peripheral Vascular Stent - Product Status
  • Table 39: Astron Peripheral Vascular Stent - Product Description
  • Table 40: Astron Pulsar Self Expanding Peripheral Stent - Product Status
  • Table 41: Astron Pulsar Self Expanding Peripheral Stent - Product Description
  • Table 42: Pulsar-18 Self Expanding Stent - Product Status
  • Table 43: Pulsar-18 Self Expanding Stent - Product Description
  • Table 44: Biotronik SE & Co. KG - Ongoing Clinical Trials Overview
  • Table 45: Astron Pulsar Self Expanding Peripheral Stent - The Treatment of Iliac and Femoral Atherosclerotic Lesions Using the Self-expanding Astron and Pulsar Stents
  • Table 46: Astron Pulsar Self Expanding Peripheral Stent - The Treatment of Iliac and Femoral Atherosclerotic Lesions Using the Self-expanding Astron and Pulsar-18 Stents (BIOFLEX-I Europe)
  • Table 47: Astron Peripheral Vascular Stent - The Treatment of Iliac and Femoral Atherosclerotic Lesions Using the Self-expanding Astron and Pulsar Stents
  • Table 48: Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 49: Cobalt-Chromium Iliac Balloon Expandable Stent - Product Status
  • Table 50: Cobalt-Chromium Iliac Balloon Expandable Stent - Product Description
  • Table 51: Innova Peripheral Vascular Drug-Eluting Stent System - Product Status
  • Table 52: Innova Peripheral Vascular Drug-Eluting Stent System - Product Description
  • Table 53: INNOVA Self-Expanding Bare-Metal Stent System - Product Status
  • Table 54: INNOVA Self-Expanding Bare-Metal Stent System - Product Description
  • Table 55: Contego Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 56: VANGUARD - Product Status
  • Table 57: VANGUARD - Product Description
  • Table 58: Cook Medical Incorporated Pipeline Products & Ongoing Clinical Trials Overview
  • Table 59: Evolution Biliary Stent System-Partially Covered - Product Status
  • Table 60: Evolution Biliary Stent System-Partially Covered - Product Description
  • Table 61: Evolution Esophageal Stent System-Fully Covered - Product Status
  • Table 62: Evolution Esophageal Stent System-Fully Covered - Product Description
  • Table 63: ZILVER PTX Drug Eluting Peripheral Stent - Product Status
  • Table 64: ZILVER PTX Drug Eluting Peripheral Stent - Product Description
  • Table 65: Zilver Vena Venous Self-Expanding Stent - Product Status
  • Table 66: Zilver Vena Venous Self-Expanding Stent - Product Description
  • Table 67: Cook Medical Incorporated - Ongoing Clinical Trials Overview
  • Table 68: ZILVER PTX Drug Eluting Peripheral Stent - Bare Metal Stent Versus Paclitaxel Eluting Stent in the Setting of Primary Stenting of Intermediate Length Femoropopliteal Lesions (BATTLE)
  • Table 69: ZILVER PTX Drug Eluting Peripheral Stent - Evaluation of the Zilver PTX Drug-Eluting Peripheral Stent for Treatment of Lesions of the Above-the-knee Femoropopliteal Artery
  • Table 70: ZILVER PTX Drug Eluting Peripheral Stent - The Cook Zilver PTX Drug-eluting Stent Versus Bypass Surgery for the Treatment The Cook Zilver PTX Drug-eluting Stent Versus Bypass Surgery of Femoropopliteal TASC C&D Lesions (ZILVERPASS)
  • Table 71: ZILVER PTX Drug Eluting Peripheral Stent - Zilver Paclitaxel(PTX) Thumbwheel Delivery System
  • Table 72: ZILVER PTX Drug Eluting Peripheral Stent - Zilver PTX Drug-Eluting Peripheral Stent Post-Approval Study
  • Table 73: ZILVER PTX Drug Eluting Peripheral Stent - Zilver PTX Post-market Surveillance Study of Paclitaxel-eluting Stents for Treating Femoropopliteal Artery Disease in Japan
  • Table 74: Zilver Vena Venous Self-Expanding Stent - Evaluation of the Zilver Vena Venous Stent
  • Table 75: Zilver Vena Venous Self-Expanding Stent - Evaluation of the Zilver Vena Venous Stent in the Treatment of Symptomatic Iliofemoral Venous Outflow Obstruction
  • Table 76: Evolution Esophageal Stent System-Fully Covered - Clinical Investigation to Evaluate Removal of the Evolution Esophageal Stent - Fully Covered
  • Table 77: Cordis Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 78: FlexStent Femoropopliteal Self Expanding Stent System - Product Status
  • Table 79: FlexStent Femoropopliteal Self Expanding Stent System - Product Description
  • Table 80: Cordis Corporation - Ongoing Clinical Trials Overview
  • Table 81: FlexStent Femoropopliteal Self Expanding Stent System - Evaluation of Safety and Efficacy of the FlexStent Femoropopliteal Self-Expanding Stent System Study
  • Table 82: CorInnova, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 83: Hybrid Dynamic Stent - Product Status
  • Table 84: Hybrid Dynamic Stent - Product Description
  • Table 85: Cytograft Tissue Engineering, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 86: LifeJacket Stent Graft - Peripheral - Product Status
  • Table 87: LifeJacket Stent Graft - Peripheral - Product Description
  • Table 88: Elixir Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 89: Peripheral Vascular Resorbable Scaffold - Product Status
  • Table 90: Peripheral Vascular Resorbable Scaffold - Product Description
  • Table 91: HEXACATH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 92: HELIOS LD Peripheral Balloon Expandable Bio Active Stent - Product Status
  • Table 93: HELIOS LD Peripheral Balloon Expandable Bio Active Stent - Product Description
  • Table 94: InspireMD, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 95: CGuard Embolic Protection System - Product Status
  • Table 96: CGuard Embolic Protection System - Product Description
  • Table 97: MGuard Carotid - Product Status
  • Table 98: MGuard Carotid - Product Description
  • Table 99: PVGuard Peripheral - Product Status
  • Table 100: PVGuard Peripheral - Product Description
  • Table 101: RGuard Renal - Product Status
  • Table 102: RGuard Renal - Product Description
  • Table 103: Lifetech Scientific (Shenzhen) Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 104: Peripheral Bare Stent - Product Status
  • Table 105: Peripheral Bare Stent - Product Description
  • Table 106: MicroVention, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 107: CASPER Carotid Stent - Product Status
  • Table 108: CASPER Carotid Stent - Product Description
  • Table 109: Nipro Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 110: Peripheral Stent - Product Status
  • Table 111: Peripheral Stent - Product Description
  • Table 112: NSVascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 113: Micropatterned TFN Stent - Product Status
  • Table 114: Micropatterned TFN Stent - Product Description
  • Table 115: Palmaz Scientific, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 116: Micro-Mesh Covered Carotid Stent - Product Status
  • Table 117: Micro-Mesh Covered Carotid Stent - Product Description
  • Table 118: Stentys, SA Pipeline Products & Ongoing Clinical Trials Overview
  • Table 119: STENTYS DES - Critical Limb Ischemia - Product Status
  • Table 120: STENTYS DES - Critical Limb Ischemia - Product Description
  • Table 121: Stron Medical Pipeline Products & Ongoing Clinical Trials Overview
  • Table 122: Biodegradable Biliary Stent - Product Status
  • Table 123: Biodegradable Biliary Stent - Product Description
  • Table 124: Tracheobronchial Stent - Product Status
  • Table 125: Tracheobronchial Stent - Product Description
  • Table 126: Taewoong Medical Co.,Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 127: Niti-S Bumpy Biliary Stent - Product Status
  • Table 128: Niti-S Bumpy Biliary Stent - Product Description
  • Table 129: Niti-S Comvi Biliary Stent - Product Status
  • Table 130: Niti-S Comvi Biliary Stent - Product Description
  • Table 131: Niti-S Giobor Biliary Stent - Product Status
  • Table 132: Niti-S Giobor Biliary Stent - Product Description
  • Table 133: Niti-S Kaffes Biliary Stent - Product Status
  • Table 134: Niti-S Kaffes Biliary Stent - Product Description
  • Table 135: Niti-S LCD Biliary Stent - Product Status
  • Table 136: Niti-S LCD Biliary Stent - Product Description
  • Table 137: Niti-S Nagi Stent - Product Status
  • Table 138: Niti-S Nagi Stent - Product Description
  • Table 139: Niti-S S Biliary Covered Stent - Product Status
  • Table 140: Niti-S S Biliary Covered Stent - Product Description
  • Table 141: Niti-S S Biliary Uncovered Stent - Product Status
  • Table 142: Niti-S S Biliary Uncovered Stent - Product Description
  • Table 143: Tepha, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 144: TephaFLEX Fully Absorbable Peripheral Stent - Product Status
  • Table 145: TephaFLEX Fully Absorbable Peripheral Stent - Product Description
  • Table 146: Terumo Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 147: MISAGO Self-expanding Stent System - Product Status
  • Table 148: MISAGO Self-expanding Stent System - Product Description
  • Table 149: Terumo Corporation - Ongoing Clinical Trials Overview
  • Table 150: MISAGO Self-expanding Stent System - Bare Metal Stent Versus Paclitaxel Eluting Stent in the Setting of Primary Stenting of Intermediate Length Femoropopliteal Lesions (BATTLE)
  • Table 151: University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview
  • Table 152: Intraluminal Stent With Seam - Product Status
  • Table 153: Intraluminal Stent With Seam - Product Description
  • Table 154: Veniti, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 155: VICI Venous Stent - Product Status
  • Table 156: VICI Venous Stent - Product Description
  • Table 157: Veniti, Inc. - Ongoing Clinical Trials Overview
  • Table 158: VICI Venous Stent - VIRTUS-OUS Safety and Efficacy of the Veniti Vici Venous Stent System (Veniti, Inc.) When Used to Treat Clinically Significant Chronic Non-malignant Obstruction of the Iliofemoral Venous Segment
  • Table 159: Veryan Medical Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 160: BioMimics 3D Stent - Product Status
  • Table 161: BioMimics 3D Stent - Product Description
  • Table 162: Veryan Medical Limited - Ongoing Clinical Trials Overview
  • Table 163: BioMimics 3D Stent - Evaluation of Safety and Effectiveness of the BioMimics 3D Stent System in the Femoropopliteal Arteries of Patients With Symptomatic Peripheral Arterial Disease: MIMICS-2
  • Table 164: VueKlar Cardiovascular Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 165: MR-Enhancing Balloon Expandable Stent - Product Status
  • Table 166: MR-Enhancing Balloon Expandable Stent - Product Description
  • Table 167: MR-Enhancing Self-Expanding Stent - Product Status
  • Table 168: MR-Enhancing Self-Expanding Stent - Product Description
  • Table 169: W. L. Gore & Associates, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 170: GORE Carotid Stent - Product Status
  • Table 171: GORE Carotid Stent - Product Description
  • Table 172: Glossary

List of Figures

  • Figure 1: Peripheral Vascular Stents - Pipeline Products by Stage of Development
  • Figure 2: Peripheral Vascular Stents - Pipeline Products by Segment
  • Figure 3: Peripheral Vascular Stents - Pipeline Products by Territory
  • Figure 4: Peripheral Vascular Stents - Pipeline Products by Regulatory Path
  • Figure 5: Peripheral Vascular Stents - Pipeline Products by Estimated Approval Date
  • Figure 6: Peripheral Vascular Stents - Ongoing Clinical Trials
Back to Top